Nematicides Market is set to grow at a CAGR of 3.0% to reach USD 1,344.5 million by 2023

Meticulous Research®, leading global market research company published a research report titled, “The Global Nematicides Market is projected to USD 1,344.5 million by 2023 growing at a CAGR of 3.0% during the forecast period of 2018 to 2023.”

Nematicides Market by Type (chemical and biological), by chemical type (fumigants, carbamates, and organophosphates), by formulation (liquid form and solid form), by mode of application (fumigation, irrigation, spraying, and seed treatment), and by crop type (fruits & vegetables, oilseeds, grains & cereals, and others) – Global Opportunity Analysis and Industry Forecast (2018 – 2023)

The study offers a comprehensive analysis of global Nematicides Market with respect to various product types, formulation, application, and crop type. The global nematicides market is mainly segmented by product type (chemical and biological), chemical type (fumigants, carbamates, and organophosphates), form (liquid and solid), mode of application (fumigation, irrigation, spraying, and seed treatment), crop type (fruits & vegetables, oilseeds, cereals & grains, and other crops), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Based on product type, chemical nematicides commanded the largest share in this market in 2017, owing to its increasing usage in developing countries, easy availability, higher efficiency, and low cost as compared to biologicals. However, the biological nematicides expected to witness the fastest growth during the forecast period, mainly due to growing environmental and public health concerns with the use of chemical nematicides, growing organic farming, increasing demand for chemical residue free agricultural products, and government support to use biological nematicides treatment across the globe.

The key players operating in the global nematicides market are Bayer CropScience AG, BASF SE, The Dow Chemical Company, Syngenta, FMC Corporation, Sumitomo Chemical Co., Ltd., Monsanto Company, Nufarm Limited, ADAMA Agricultural Solutions Ltd., AMVAC Chemical Corporation, Brandt Consolidated, Inc., Isagro S.p.A., Marrone Bio Innovations Inc., and Certis USA L.L.C.

                        Hurry Up Limited Period Offer To Get Free Sample Report Now !!           

          

Scope of the Report

Market by Product Type

·         Chemical

·         Fumigants

·         Carbamates

·         Organophosphate

·         Biological 

Market by Form

·         Liquid form

·         Solid form

Market by Mode of Application

·         Fumigation

·         Irrigation

·         Spraying

·         Seed Treatment              

Market by Crop Type

·         Fruits and Vegetables

·         Oilseeds

·         Cereals & Grains

·         Other Crops

                             TOP 10 COMPANIES IN GLOBAL NEMATICIDES MARKET

Market by Geography

·         North America

·         U.S.

·         Canada

·         Mexico

·         Europe

·         Spain

·         Italy

·         Germany

·         France

·         Rest of Europe

·         Asia-Pacific

·         Japan

·         China

·         India

·         Rest of Asia-Pacific

·         Rest of World

·         Latin America

·         Brazil

·         Argentina

·         Chile

·         Rest of LATAM

·         Middle East & Africa

The report also includes the competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the detailed profiles of 14 top market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.           

                              Click Here To Download Free Sample Report Immediately

Contact -

Viren Shrivastava

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+91 744-7780008 (Asia-Pacific)

Molecular Cytogenetics Market Worth 2,266.4 Million USD By 2022

Meticulous Research®, leading global market research company published a research report titled, “The Global Molecular Cytogenetics Market is projected to reach $2,266.4 million by 2022 growing at a CAGR of 11.0% during the forecast period of 2017 to 2022.”

This growth is primarily driven by the increasing focus on preventive healthcare measures, increasing genetic abnormalities; growing aging population and subsequent increase in chronic diseases, increasing need to reduce mounting healthcare cost, and rising focus on clinical and research diagnosis.

Molecular cytogenetics plays an important role in diagnosis of various diseases. Based on the type of diseases, the diagnosis can be possible using various cytogenetic techniques such as Fluorescence In Situ Hybridization (FISH), In Situ Hybridization, Karyotyping, Banding Techniques, and others. The banding techniques have been used since past decades because of their easy accessibility and availability. However, due to its drawbacks in identifying genetic diseases at submicroscopic level, it is further modified into in situ hybridization. Currently, the FISH plays a major role in diagnosis of various diseases at genetic level using advanced molecular cytogenetic products.

FISH is mainly used to detect the chromosomal aberrations such as deletion, duplication, insertion, and gene expression. It can be applicable to any specimen. Also, it is suitable for heterogeneous breakpoints or multiple translocation patterns. However, it has less sensitivity for detecting the genetic abnormality and requires expertise to interpret the results as there is a risk of getting false positive results. However, with the growing need to diagnose diseases at molecular level, array-based technologies have emerged and preferred over FISH technique.

Read full Research Report Study On 

https://www.meticulousresearch.com/product/molecular-cytogenetics-market/

Array based techniques are preferred over FISH since the high resolution, locus specific analysis, and genome wide evaluation are combined in a single technique. Also, the sensitivity of these techniques is high compared to FISH which is useful for researchers in the detection of microdeletions. The array-based techniques are used in detection of any type of cancers since they are able to screen whole genome variations compared to FISH. The microarray uses 1000 probes at a time, whereas FISH uses only one probe. The use of these many probes at a time makes the diagnosis easy and quick. This technique is also useful in the detection of abnormalities in all 24 chromosomes, whereas FISH has limit up to 12 chromosomes.

The report provides meticulous analysis of Molecular Cytogenetics Market on the basis of technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), product (instruments, kits and reagents, software, services, and consumable/accessories), application (oncology, genetic disorders, personalized medicines, and other), end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes), and geography.

The use of array is mostly in detection of copy number variations which is not applicable for FISH. Thus, because of the number of benefits provided by array-based techniques, their use by various end users is increasing for both qualitative and quantitative detection of genetic diseases. These techniques not only improve the sensitivity of diagnosis but also the accuracy of results. This transition helps in use of diagnostic products to large extent.

The major companies such as Thermo Fisher Scientific, Illumina Inc., Agilent Technologies, and Oxford Gene Technology are manufacturing array-based products in order to accelerate research. They are providing sophisticated technology for running thousands of samples at a time to analyze genetic variations efficiently.

Hurry Up To Get Your Free Sample Report Now!

https://www.meticulousresearch.com/request-sample-report/?cp_id=3067

The key players analyzed in the molecular cytogenetics market are Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Bio-Rad Laboratories (U.S.), Applied Spectral Imaging (U.S.), Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland) , Danaher Corporation (U.S.), Illumina (U.S.), and Oxford Gene Technology (U.S.).

Contact -

Viren Shrivastava

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+91 744-7780008 (Asia-Pacific)

Diabetes Care Devices Market Worth 26,710.3 Million USD By 2022

Meticulous Research®, leading global market research company published a research report titled, “The Global Diabetes Care Devices Market is projected to $26,710.3 million by 2022 growing at a CAGR of 5.3% during the forecast period of 2017 to 2022.”

The significant growth in diabetes population is primarily attributed to the rising obesity rates across the globe, and increasing sedentary lifestyle with poor diets and lowered physical inactivity. According to the World Health Organization (WHO), in 2014, around 39% adults were overweight. Of these about 13% of the world’s adult population were obese; and almost half the world will be overweight or obese by 2030. With increasing levels of obesity and physical inactivity among children in many countries, type 2 diabetes in childhood has the potential to become a global public health issue, leading to serious health outcomes. The ignorance of the diabetes at early stage can lead to many severe complications, including increased risk of cardiovascular diseases and kidney disorders and thereby huge financial implications.

Thus, the rising diabetic population across the globe will propel the number of people who must be monitored with the periodic monitoring of their blood glucose, thereby leading to a growing demand for diabetes care devices.

Diabetes Care Devices Market by Monitoring Devices (Test Strips, Self-Monitoring Devices, CGM Devices, Lancets, Hemoglobin A1c Testing Kits) and Insulin Delivery Devices (Insulin Pens, Insulin Syringes, Insulin Pumps, Insulin Jet Injectors) – Global Opportunity Analysis and Industry Forecast To 2022.

Read full Research Report Study On

https://www.meticulousresearch.com/product/diabetes-care-devices-market-2022/

Global Diabetes Care Devices Market is driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. Moreover, various developments of new technologies for the delivery of insulin further provide significant opportunities in this market. However, high cost associated with the diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of diabetes care devices market to some extent.

Scope of the Report

Market by Type

Diabetes monitoring devices

– Test strips

– Self-monitoring devices

– Continuous blood glucose monitoring devices

– Lancets

– Hemoglobin A1c testing kits

Insulin delivery devices

– Insulin Pens

– Insulin Syringes

– Insulin Pumps

– Insulin Jet Injector

The insulin pens held the largest share of the global insulin delivery devices market in 2016, mainly due to their rising adoption with several advantages over the traditional syringe method of insulin delivery, including improved patient satisfaction and adherence, user-friendliness, superior accuracy for delivering small doses of insulin, greater social acceptability, and less reported injection pain.

The key players in the global diabetes care devices market are Novo Nordisk A/S, Ypsomed AG, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic, Becton, Dickinson and Company, Terumo Corporation, and Sanofi AS.

Hurry Up To Get Your Free Sample Report Now!

https://www.meticulousresearch.com/request-sample-report/?cp_id=3438

Contact -

Viren Shrivastava

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+91 744-7780008 (Asia-Pacific)

Vaccines Market 2018-2025 | Extensive Analysis On Worldwide Industry and New Market Opportunities.

Meticulous Research®, leading global market research company published a research report titled, “The Global Vaccines Market is projected to $57.50 billion by 2025 growing at a CAGR of 7.9% during the forecast period of 2018 to 2025.”

The Global Vaccines Market study presents historical market data in terms of values (2016 and 2017), estimated current data (2018), and forecasts for 2025-Vaccines Market By Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography.

In 2017, the pneumococcal disease accounted for the largest share of the global vaccines market. The large share of this segment is mainly attributed to the high prevalence of pneumococcal disease in pediatric, elderly, and immunocompromised populations. In addition, growing number of pneumococcal diseases associated with chronic disease patients is further driving the adoption of pneumococcal vaccines. However, meningococcal disease vaccine segment is expected to grow at the highest CAGR in the next 5-7 years.

The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.

The global vaccines market is highly competitive with the presence of many players worldwide. With four big pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the vaccine industry is highly consolidated. CSL Limited, Emergent BioSolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and AstraZeneca are the other leading players of the global vaccines market. All these players are focusing more on technologically-advanced vaccine products.

Read full Research Report Study On

https://www.meticulousresearch.com/product/vaccines-market/

North America accounted for the largest share of the vaccines market with its well-established vaccination program. In addition, factors such as the increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players are further expected to propel the growth of vaccines market in this region.

The intramuscular accounted for the largest share of the vaccines market. The large share of this segment is mainly due to the availability of wide range of vaccines for IM.

Key Topics Covered in This Report:

1.    Introduction

2.    Research Methodology

3.    Executive Summary

4.    Market Share Analysis

5.    Market Insights

6.    Global Vaccines Market, by Indication

7.    Global Vaccines Market, by Route of Administration

8.   Global Vaccines Market, by Type/Antigen

9.    Global Vaccines Market, by Valence

10. Vaccines Market, by Region

11.  Competitive Landscape

12. Company Profiles

13. Appendix

Hurry Up To Get Your Free Sample Report Now!

https://www.meticulousresearch.com/download-sample-report/?cp_id=4813

The Asia-Pacific vaccines market is expected to grow at the highest CAGR of 8.9%. The growth in the APAC market is mainly attributed to large patient pool, rising prevalence of diseases, growing awareness on vaccination, increasing government initiatives, and expanding presence of key players in this region. In addition, increasing disposable income and growing awareness about heath in emerging countries are further propelling the demand for vaccines in APAC region.

Contact -

Viren Shrivastava

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+91 744-7780008 (Asia-Pacific)

With CAGR 7.0% The Sterilization Equipment Market Reach $10.51 billion by 2023.

 “Meticulous Research” in its latest publication states that, “the Global Sterilization Equipment Market is projected to reach USD 10.51 billion by 2023 growing at a CAGR of 7.0% during the forecast period of 2018 to 2023.”

Sterilization Equipment Market By Product And Service [Equipment (Moist Heat, Dry Heat, Hydrogen Peroxide, Ethylene Oxide), Consumables (Sterilization Indicators, Sterilant Cassettes), Services (E-Beam, EtO, Gamma)]– Global Forecast To 2023.

Sterilization is one of the key processes in many of the industries, specifically in healthcare services. It is widely used in hospitals to prevent hospital acquired infections, and in pharmaceutical and biotechnology, medical device manufacturing, and food and beverages processing industry to maintain sterile processing environment within the facility, as per need. In industrial applications, sterilization hold importance as it helps manufacturers in ensuring GMP compliance.

This growth is primarily driven by the growing need to curb the incidence of HAIs (Hospital Acquired Infections) among healthcare facilities across the globe and thereby curtail the added burden of hospital readmissions. At the same time, increasing number of surgical procedures being performed across the globe, growing medical device and pharma manufacturing, and increasing use of sterilization technologies in the food and beverages industry is also expected to contribute to the growth of the sterilization technologies market.

Click Here To Get Your Free Sample Report Now! https://www.meticulousresearch.com/download-sample-report/?cp_id=4698

Growing Adoption of E-beam Sterilization Fuels the Growth of the Sterilization Equipment Market. -

E-beam sterilization is one of the most recent radiation sterilization technologies in the global sterilization equipment market. It offers several benefits over conventional methods of sterilization in the form of ability to sterilize low-density medical devices packaged in boxes and shorter sterilization cycles. Its compatibility with heat sensitive materials that are used in majority of the advanced medical devices currently offered in the market is one of the major factors driving greater adoption of e-beam sterilization technologies among both in-house sterilization facilities of various end users and contract sterilization service providers.               

Rapid Growth in Medical Device & Pharmaceutical Industry in Emerging Economies Supports the Sterilization Equipment Market Growth -

India and China are some of the largest exporters of pharmaceutical products to the global market. Considering the international requirements of manufacturing, the medical device and pharmaceutical device manufacturers in this region are increasingly adopting global sterilization practices. This has compelled manufacturers in the region to use advanced sterilization technologies, such as gamma sterilization, e-beam sterilization that are more effective than the conventional technologies such as steam sterilization.

Hospitals and Clinics Will Continue to Dominate the Sterilization Equipment Market by 2023 -

The need to prevent HAIs and improve quality of care provided at healthcare facilities is one of the key factors propelling the growth of the sterilization technologies market globally. As sterilization is most important defense against HAIs, it is an integral part of government initiatives to curb these additional costs. This in turn is contributing to the increasing demand for sterilization equipment and clinics among hospitals and clinics.

The key players analyzed in the sterilization equipment market are STERIS plc, Getinge AB, 3M Company, MMM Goup, Matachana Group, Belimed AG, Sotera Health, Cardinal Health, Advanced, Sterilization Products Services Inc., and Cantel Medical Corporation.

The Global sterilization equipment market study, published by Meticulous Research, can be accessed at:

https://www.meticulousresearch.com/product/sterilization-equipment-market/

Contact -

Viren Shrivastava

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+91 744-7780008 (Asia-Pacific)